Alkem Laboratories Ltd News
Cipla, Ipca Lab, Zydus Life to benefit most from drug price rise: Analysts_48612
The recent price hike, analysts said, brings some respite for the industry facing multiple headwinds such as steep raw inflation, price erosion in the US market and higher freight costs.
 "Cipla, Ipca Lab, Zydus Life to benefit most from drug price rise: Analysts_48612")
Updated On : 30 Mar 2022 | 10:25 AM IST
BSE Healthcare index up 2%; Cipla, Alkem, Dr.Reddy's rally up to 8%_210
The pharma index had taken a breather over the past three months after displaying relative out-performance during CY20-21.
 "BSE Healthcare index up 2%; Cipla, Alkem, Dr.Reddy's rally up to 8%_210")
Updated On : 26 Nov 2021 | 1:59 PM IST
